Back to search

Bensen Therapeutics Limited

06025726

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

RUFFINS BARN BROOKSIDE, NEWMARKET, CB8 8TG
Incorporated 12/12/2006

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

74990
Non-trading company

Officers

Mr Andrew Richard Boyce

director · Since 08/06/2023

DIRECTOR

BRITISH · ENGLAND · Age 64

Also on 25 other boards

Persons with Significant Control

Bensen Pharma Limited

75–100% shares
75–100% votes

Ruffins Barn, Brookside, Newmarket, CB8 8TG

Reg: 14844370 · Registrar Of Companies In England And Wales · Limited Company

Notified 08/06/2023

Former PSCs

Atlantic Healthcare Plc

Ceased 08/06/2023

Charges0 outstanding

charge
satisfied

FE LOAN MANAGEMENT LIMITED

Created 17/12/2010Registered 29/12/2010Satisfied 17/02/2014

CompanyRankvs 3873+ SIC 74990 peers
62

Financial strength94th percentile among SIC peers · 24/25
Employees53th percentile among SIC peers · 8/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees8/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£254k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

Debtors

£1

0avg. employees

Balance Sheet

Intangible assets£254k
Signed by 06025726 2024-01-01 2024-12-31 06025726 2024-12-31 06025726 core:RetainedEarningsAccumulatedLosses 2024-12-31 06025726 cPrepared with Digita Accounts Production Advanced

EstimatesDerived

YearImplied Profit
2024+£0
2023-£786k
2021+£0

Derived from filed accounts. Not audited figures.